TABLE 4.

CEPCs, CECs and their ratio in hypertensive men with and without LVH.

	MH ♂		Control ♂
Parameter	LVH (−)	LVH (+)
CECs/4 ml	140 (65–251)	107 (40–155)	44 (13–75)*
CEPCs/4 ml	167 (106–406)	130 (88–1296)	119 (75–220)
CEPCs/CECs	1.55 (1.02–1.86)	2.25 (1.47–10.82)	3.24 (2.09–13.14)*
	RH ♂		Control ♂
Parameter	LVH (−)	LVH (+)
CECs/4 ml	102 (68–168)	223 (110–321)∗∗	44 (13–75)*
CEPCs/4 ml	164 (123–221)	280 (129–629)	119 (75–220)∗∗∗
CEPCs/CECs	1.60 (1.31–1.81)	1.33 (0.82–2.79)	3.24 (2.09–13.14)*

Results shown as median and interquartile range, comparison done by using Kruskal-Wallis test followed by the Dunn’s multiple comparison test ^*LVH(−), LVH(+) vs. Control p ≤ 0.05, ^∗∗LVH(+) vs. LVH(−) p ≤ 0.05, ^∗∗∗ LVH(+) vs. Control p ≤ 0.05.